Federal Register / Vol. 74, No. 194 / Thursday, October 8, 2009 / Notices 51869 

contacting Dr. Ruth Lunn (see FOR

FURTHER INFORMATION CONTACT above). 

NTP will send registrants instructions to 

access the meeting remotely on or before 

October 30, 2009. Web conferencing is 

a new remote access option for RoC 

meetings. NTP will make every effort to 

ensure the best possible technical 

quality for these remote access options, 

but the audio and video quality cannot 

be guaranteed. 

Attendees registered for remote access 

are invited to present oral comments. 

The formal public comment period is 

scheduled for November 2, 2009. Oral 

public comments should not exceed 7 

minutes in length and each organization 

is allowed only one comment slot (in 

person or by remote access). Every effort 

will be made to accommodate the 

public, but the total time allotted for 

oral comments and the time allotted per 

speaker by remote access will depend 

on the number of people who register 

online to speak. Remote speakers who 

wish to use slides with their oral 

comments, must send an electronic file 

to Dr. Lunn by October 28, 2009, for the 

slides to be available for Web 

conferencing. In addition, speakers may 

send a copy of their oral statement or 

talking points, which can supplement 

and/or expand the oral presentation, for 

distribution at the meeting and for the 

meeting record. 

Updated Draft Agenda 

The updated draft agenda includes a 

scientific presentation on formaldehyde 

and leukemia requested by the NTP. 

Following this presentation, there will 

be opportunity for public comments on 

this topic. Pre-registration is not 

required to comment on this topic, and 

there is a 3-minute limit for each 

speaker. 

Details about the meeting, including 

the updated draft agenda, are available 

at http://ntp.niehs.nih.gov/go/29679 or 

by contacting Dr. Lunn (see FOR FURTHER

INFORMATION CONTACT above). Updates to 

the meeting will be posted on this Web 

site. 

Dated: October 1, 2009. 

John R. Bucher, 

Associate Director, National Toxicology 

Program. 

[FR Doc. E9–24345 Filed 10–7–09; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Office of the Director, National 

Institutes of Health; Notice of Meeting 

Pursuant to section 10(a) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of a meeting of the Council 

of Councils. 

The meeting will be open to the 

public, with attendance limited to space 

available. Individuals who plan to 

attend and need special assistance, such 

as sign language interpretation or other 

reasonable accommodations, should 

notify the Contact Person listed below 

in advance of the meeting. 

Name of Committee: Council of Councils. 

Date: November 16–17, 2009. 

Time: 9 a.m. to 12 p.m. 

Agenda: Among the topics proposed for 

discussion are: updates on the Common 

Fund, American Recovery and Reinvestment 

Act, and NIH Roadmap initiatives; role of the 

Council. 

Place: National Institutes of Health, 

Building 31C, 31 Center Drive, Conference 

Room 6, Bethesda, MD 20892. 

Contact Person: Robin Kawazoe, Executive 

Secretary, Division of Program Coordination, 

Planning, and Strategic Initiatives, Office of 

the Director, NIH, Building 1, Room 260B, 

Bethesda, MD 20892, 

kawazoer@mail.nih.gov. 

Any interested person may file written 

comments with the committee by forwarding 

the statement to the Contact Person listed on 

this notice. The statement should include the 

name, address, telephone number and when 

applicable, the business or professional 

affiliation of the interested person. 

In the interest of security, NIH has 

instituted stringent procedures for entrance 

onto the NIH campus. All visitor vehicles, 

including taxicabs, hotel, and airport shuffles 

will be inspected before being allowed on 

campus. Visitors will be asked to show one 

form of identification (for example, a 

government-issued photo ID, driver’s license, 

or passport) and to state the purpose of their 

visit. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.14, Intramural Research 

Training Award; 93.22, Clinical Research 

Loan Repayment Program for Individuals 

from Disadvantaged Backgrounds; 93.232, 

Loan Repayment Program for Research 

Generally; 93.39, Academic Research 

Enhancement Award; 93.936, NIH Acquired 

Immunodeficiency Syndrome Research Loan 

Repayment Program; 93.187, Undergraduate 

Scholarship Program for Individuals from 

Disadvantaged Backgrounds, National 

Institutes of Health, HHS) 

Dated: September 29, 2009. 

Jennifer Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. E9–24279 Filed 10–7–09; 8:45 am] 

BILLING CODE 4140–01–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

National Health and Nutrition 

Examination Survey (NHANES) DNA 

Samples: Guidelines for Proposals To 

Use Samples and Cost Schedule 

[Correction] 

The notice ‘‘National Health and 

Nutrition Examination Survey 

(NHANES) DNA Samples: Guidelines 

for Proposals to Use Samples and Cost 

Schedule,’’ was published in the 

Federal Register on September 3rd, 

2009, (Vol. 74 FR No. 170). This notice 

is corrected as follows: 

On page 45647 first column, under 

Public Availability of Data, the Web site 

should read: http://www.cdc.gov/nchs/ 

nhanes/genetics/genetic_types.htm. 

Proposals for secondary data analyses 

linking NHANES public use data with 

genetic variation data will be reviewed 

by the Research Data Center see: 

http://www.cdc.gov/nchs/r&d/rdc.htm 

for proposal guidelines. 

Dated: October 1, 2009. 

James Stephens, 

Associate Director for Science, Centers for 

Disease Control and Prevention. 

[FR Doc. E9–24297 Filed 10–7–09; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

ODS Nutrient Biomarkers Analytical 

Methodology: Vitamin D Workshop; 

Notice 

Notice is hereby given of the National 

Institutes of Health (NIH) Office of 

Dietary Supplements (ODS) Nutrient 

Biomarkers Analytical Methodology: 

Vitamin D Workshop to be held 

Wednesday, December 16, 2009 at the 

Bethesda North Marriott Hotel & 

Conference Center in Bethesda, 

Maryland 20852. 

Summary: Vitamin D is a fat-soluble 

vitamin that is naturally present in very 

few foods, added to others, and 

available as a dietary supplement. It is 

also produced endogenously when 

ultraviolet rays from sunlight strike the 

mstockstill on DSKH9S0YB1PROD with NOTICES